Roivant Sciences Ltd.

NasdaqGS:ROIV Stock Report

Market Cap: US$15.5b

Roivant Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ROIV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Dec 25SellUS$39,065,213QVT Financial LPCompany1,694,614US$23.17
19 Nov 25SellUS$26,304,500QVT Financial LPCompany1,300,000US$20.25
17 Nov 25SellUS$37,939,112Vivek RamaswamyIndividual1,854,603US$20.81
23 Sep 25SellUS$17,116,182Eric VenkerIndividual1,148,626US$14.95
18 Sep 25BuyUS$49,957Matthew GlineIndividual3,315US$15.07
05 Sep 25SellUS$22,456,210Vivek RamaswamyIndividual1,775,749US$12.96
20 Jun 25SellUS$13,084,796Vivek RamaswamyIndividual1,142,273US$11.46
06 Jun 25SellUS$8,454,808Vivek RamaswamyIndividual748,230US$11.34
07 May 25SellUS$10,129,810Vivek RamaswamyIndividual898,959US$11.47
13 Feb 25SellUS$417,200Rakhi KumarIndividual40,000US$10.43

Insider Trading Volume

Insider Buying: ROIV insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ROIV?
Owner TypeNumber of SharesOwnership Percentage
State or Government350,7650.0481%
Private Companies6,341,8280.869%
General Public23,837,9663.27%
Hedge Funds34,237,7794.69%
VC/PE Firms40,315,1275.52%
Individual Insiders162,560,95822.3%
Institutions462,084,97163.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Dan Oren
102,849,443US$2.3b4.77%no data
8.73%
FMR LLC
60,736,221US$1.4b9.47%0.07%
6.76%
Vivek Ramaswamy
47,011,612US$1.0b-3.8%no data
5.8%
SB Investment Advisers (UK) Limited
40,315,127US$896.2m-32.8%4.61%
5.78%
Morgan Stanley Investment Management Inc.
40,198,064US$893.6m20.5%0.67%
5.71%
BlackRock, Inc.
39,724,829US$883.1m-1.47%0.01%
5.58%
The Vanguard Group, Inc.
38,804,928US$862.6m-1.33%0.01%
3.79%
QVT Financial LP
26,387,021US$586.6m-10.2%42.7%
3.39%
Viking Global Investors LP
23,594,831US$524.5m-31.1%1.33%
2.88%
Rubric Capital Management LP
20,000,000US$444.6m-1.82%5.72%
2.69%
State Street Global Advisors, Inc.
18,700,144US$415.7m-5.43%0.01%
1.79%
Patient Square Capital, LP
12,480,000US$277.4m0%53.54%
1.69%
Two Seas Capital LP
11,754,164US$261.3m10.9%14.59%
1.34%
Dimensional Fund Advisors LP
9,308,710US$206.9m18.1%0.03%
1.29%
Daniel Gold
8,951,370US$199.0m0%no data
1.18%
Geode Capital Management, LLC
8,202,594US$182.3m5.83%0.01%
1.06%
Perceptive Advisors LLC
7,368,461US$163.8m121%3.45%
1.04%
Adage Capital Management, L.P.
7,232,383US$160.8m247%0.24%
0.7%
UBS Asset Management AG
4,868,573US$108.2m-38.1%0.01%
0.67%
Dexcel Ltd.
4,684,130US$104.1m0%no data
0.66%
BNY Asset Management
4,563,396US$101.4m2.67%0.02%
0.63%
BlackBarn Capital Partners LP
4,400,000US$97.8m-4.86%27.11%
0.6%
StemPoint Capital LP
4,197,187US$93.3m597%14.68%
0.57%
Marshall Wace LLP
3,978,001US$88.4m316%0.11%
0.54%
Baker Bros. Advisors LP
3,767,773US$83.8m0%0.45%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/29 06:47
End of Day Share Price 2025/12/29 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Roivant Sciences Ltd. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chi Meng FongBofA Global Research
Louise ChenCantor Fitzgerald & Co.
Prakhar AgrawalCantor Fitzgerald & Co.